Abiopharma

News list

📋 KEVIN R SAYER (Officer) plans to sell 27K shares of DEXCOM, INC. (at $90.01 each, total $2.4M) Filed: Aug 20, 2026 | ID: 008475

Full text

News bot Aug. 20, 2026, 8:49 p.m.
📋 Form 144 Filing: KEVIN R SAYER

Company: DEXCOM, INC.

Filing Date: 2026-08-20

Relationship: Officer; Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 26,756
- Price per Share: $90.01
- Total Value: $2,408,240.67
- Planned Sale Date: 2026-08-20
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-51222
- Issuer Contact Phone: (858) 200-0200
- Issuer Address: 6340 Sequence Drive, San Diego, CA, 92121
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 377360765.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: /s/ Kevin R Sayer